Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.

Nickel MK, Muehlbacher M, Nickel C, Kettler C, Pedrosa Gil F, Bachler E, Buschmann W, Rother N, Fartacek R, Egger C, Anvar J, Rother WK, Loew TH, Kaplan P.

Am J Psychiatry. 2006 May;163(5):833-8.

PMID:
16648324
2.

Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.

Bellino S, Paradiso E, Bogetto F.

Psychiatry Res. 2008 Nov 30;161(2):206-12. doi: 10.1016/j.psychres.2007.07.006. Epub 2008 Oct 9.

PMID:
18848360
3.

Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up.

Nickel MK, Loew TH, Pedrosa Gil F.

Psychopharmacology (Berl). 2007 May;191(4):1023-6. Epub 2007 Feb 23.

PMID:
17318503
4.

Aripiprazole pharmacotherapy of borderline personality disorder.

Mobascher A, Mobascher J, Schlemper V, Winterer G, Malevani J.

Pharmacopsychiatry. 2006 May;39(3):111-2.

PMID:
16721700
5.

Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study.

Tritt K, Nickel C, Lahmann C, Leiberich PK, Rother WK, Loew TH, Nickel MK.

J Psychopharmacol. 2005 May;19(3):287-91.

PMID:
15888514
6.

Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.

Nickel MK, Nickel C, Mitterlehner FO, Tritt K, Lahmann C, Leiberich PK, Rother WK, Loew TH.

J Clin Psychiatry. 2004 Nov;65(11):1515-9.

PMID:
15554765
7.

Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.

Lin CH, Lin SH, Jang FL.

J Clin Psychopharmacol. 2011 Oct;31(5):563-8. doi: 10.1097/JCP.0b013e31822bb0db.

PMID:
21869699
8.

Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.

Bellino S, Paradiso E, Bogetto F.

J Clin Psychiatry. 2006 Jul;67(7):1042-6.

PMID:
16889446
9.

Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study.

Loew TH, Nickel MK, Muehlbacher M, Kaplan P, Nickel C, Kettler C, Fartacek R, Lahmann C, Buschmann W, Tritt K, Bachler E, Mitterlehner F, Pedrosa Gil F, Leiberich P, Rother WK, Egger C.

J Clin Psychopharmacol. 2006 Feb;26(1):61-6.

PMID:
16415708
10.

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.

Potkin SG, Saha AR, Kujawa MJ, Carson WH, Ali M, Stock E, Stringfellow J, Ingenito G, Marder SR.

Arch Gen Psychiatry. 2003 Jul;60(7):681-90.

PMID:
12860772
12.

Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.

Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB.

Am J Psychiatry. 2005 Mar;162(3):621-4.

PMID:
15741486
13.

Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.

Keck PE, Orsulak PJ, Cutler AJ, Sanchez R, Torbeyns A, Marcus RN, McQuade RD, Carson WH; CN138-135 Study Group.

J Affect Disord. 2009 Jan;112(1-3):36-49. doi: 10.1016/j.jad.2008.05.014. Epub 2008 Oct 2.

PMID:
18835043
14.

Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.

Mintzer JE, Tune LE, Breder CD, Swanink R, Marcus RN, McQuade RD, Forbes A.

Am J Geriatr Psychiatry. 2007 Nov;15(11):918-31.

PMID:
17974864
15.

Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study.

Nickel MK, Nickel C, Kaplan P, Lahmann C, Mühlbacher M, Tritt K, Krawczyk J, Leiberich PK, Rother WK, Loew TH.

Biol Psychiatry. 2005 Mar 1;57(5):495-9.

PMID:
15737664
16.

The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.

Glick ID, Mankoski R, Eudicone JM, Marcus RN, Tran QV, Assunção-Talbott S.

J Affect Disord. 2009 May;115(1-2):18-26. doi: 10.1016/j.jad.2008.12.017. Epub 2009 Feb 23.

PMID:
19230981
17.

Aripiprazole in schizophrenia and schizoaffective disorder: A review.

Stip E, Tourjman V.

Clin Ther. 2010;32 Suppl 1:S3-20. doi: 10.1016/j.clinthera.2010.01.021. Review.

PMID:
20152550
18.

Efficacy of phenelzine and haloperidol in borderline personality disorder.

Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF.

Arch Gen Psychiatry. 1993 May;50(5):377-85.

PMID:
8489326
19.

Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.

Trivedi MH, Thase ME, Fava M, Nelson CJ, Yang H, Qi Y, Tran QV, Pikalov A, Carlson BX, Marcus RN, Berman RM.

J Clin Psychiatry. 2008 Dec;69(12):1928-36. Epub 2008 Dec 2.

PMID:
19192475
20.

A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).

Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M.

Psychother Psychosom. 2012;81(2):87-97. doi: 10.1159/000332050. Epub 2012 Jan 25. Erratum in: Psychother Psychosom. 2012;81(4):261.

PMID:
22286203

Supplemental Content

Support Center